HD vs TSLA: Which Is the Better Buy?

Side-by-side comparison of The Home Depot, Inc. and Tesla, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
The Home Depot, Inc. ยท Consumer Cyclical
$337.34
+12.1% upside to fair value
Med Conviction Grade B
VS
Tesla, Inc. ยท Consumer Cyclical
$343.23
-5.3% upside to fair value
Low Conviction Grade D
QuantHub Verdict
HD has more upside to fair value (+12.1%). HD trades at a lower forward P/E (23.0x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric HD TSLA
Current Price $337.34 $343.23
Fair Value Estimate $378.00 $325.00
Upside to Fair Value +12.1% -5.3%
Market Cap $336.0B $1,287.9B
Forward P/E 23.0x 205.5x
EV / EBITDA 18.1x 108.8x
Price / Sales 2.3x 13.6x
Price / FCF 29.7x 207.1x
Revenue Growth YoY +3.2% -2.9%
Gross Margin 33.3% 18.0%
Operating Margin 12.7% 4.6%
Return on Equity 110.5% 4.8%
Dividend Yield 2.44% 0%
FCF Yield 3.37% 0.48%
Analyst Consensus Buy โ€”
Investment Thesis
HD โ€” The Home Depot, Inc.
Home Depot remains the world's largest home improvement retailer with 2,350+ stores, dominant 52% market share, and a rapidly growing Pro contractor segment bolstered by the SRS Distribution acquisition. The stock has declined 21% from its $427 high to $337, but now trades at 2.28x P/S, near the 5-year median of 2.31x, and 26.5x P/E which is above the 5-year median of 23.5x. EPS declined 4.6% in โ€ฆ
TSLA โ€” Tesla, Inc.
Tesla remains the most polarizing stock in markets. The core auto business is deteriorating: FY2025 revenue fell 2.9% to $94.8B, net income dropped 46.8% to $3.8B, and Q4 deliveries declined 15.6% YoY to 418K units. Yet the stock trades at 13.6x TTM P/S (near 5yr highs) on the optionality of Cybercab robotaxis launching April 2026, FSD reaching unsupervised status in Austin, and Optimus humanoid โ€ฆ
Accumulation Zones
Metric HD TSLA
Zone Low $285.00 $244.00
Zone High $320.00 $276.00
In Buy Zone? No No
โ† HD Research    TSLA Research โ†’    All Research